Transglutaminase binding fusion protein linked to SLPI reduced corneal inflammation and neovascularization
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2415
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Transglutaminase binding fusion protein linked to SLPI reduced corneal inflammation and neovascularization ; volume:15 ; number:1 ; day:4 ; month:2 ; year:2015 ; pages:1-10 ; date:12.2015
BMC ophthalmology ; 15, Heft 1 (4.2.2015), 1-10, 12.2015
- Creator
-
Salica, Juan P.
- Contributor
-
Guerrieri, Diego
Maffia, Paulo
Croxatto, Juan O.
Chuluyan, H Eduardo
Gallo, Juan E.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2415-15-12
- URN
-
urn:nbn:de:101:1-2018080901392906525389
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Salica, Juan P.
- Guerrieri, Diego
- Maffia, Paulo
- Croxatto, Juan O.
- Chuluyan, H Eduardo
- Gallo, Juan E.
- SpringerLink (Online service)
Other Objects (12)
Therapeutic approaches for corneal neovascularization
Inhibition of corneal neovascularization with propolis extract
Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo
Resolution of Refractory Corneal Neovascularization with Subconjunctival Bevacizumab
Angiogenin ameliorates corneal opacity and neovascularization via regulating immune response in corneal fibroblasts
MiR-335 promotes corneal neovascularization by Targeting EGFR
Inhibitory effect of anti-Scg3 on corneal neovascularization: a preliminary study
Cannabinoid (JWH-133) therapy could be effective for treatment of corneal neovascularization
Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo (Adv. Sci. 25/2024)
B-cell leukemia/lymphoma 10 promotes angiogenesis in an experimental corneal neovascularization model
Plasmodium falciparum liver stage antigen-1 is cross-linked by tissue transglutaminase
Transglutaminase-induzierte und Transglutaminase-unterstützte Gele aus Milchproteinen
Therapeutic approaches for corneal neovascularization
Inhibition of corneal neovascularization with propolis extract
Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo
Resolution of Refractory Corneal Neovascularization with Subconjunctival Bevacizumab
Angiogenin ameliorates corneal opacity and neovascularization via regulating immune response in corneal fibroblasts
MiR-335 promotes corneal neovascularization by Targeting EGFR
Inhibitory effect of anti-Scg3 on corneal neovascularization: a preliminary study
Cannabinoid (JWH-133) therapy could be effective for treatment of corneal neovascularization
Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo (Adv. Sci. 25/2024)
B-cell leukemia/lymphoma 10 promotes angiogenesis in an experimental corneal neovascularization model
Plasmodium falciparum liver stage antigen-1 is cross-linked by tissue transglutaminase
Transglutaminase-induzierte und Transglutaminase-unterstützte Gele aus Milchproteinen
Therapeutic approaches for corneal neovascularization
Inhibition of corneal neovascularization with propolis extract
Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo
Resolution of Refractory Corneal Neovascularization with Subconjunctival Bevacizumab
Angiogenin ameliorates corneal opacity and neovascularization via regulating immune response in corneal fibroblasts
MiR-335 promotes corneal neovascularization by Targeting EGFR
Inhibitory effect of anti-Scg3 on corneal neovascularization: a preliminary study
Cannabinoid (JWH-133) therapy could be effective for treatment of corneal neovascularization
Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo (Adv. Sci. 25/2024)
B-cell leukemia/lymphoma 10 promotes angiogenesis in an experimental corneal neovascularization model
Plasmodium falciparum liver stage antigen-1 is cross-linked by tissue transglutaminase